Duncan Charles Cliff bought VNDA
June 4, 2026 · Form 4 insider transaction
Duncan Charles Cliff bought 41,600 shares of Vanda Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
41,600
Price
$0.00
Total value
N/A
InsiderDuncan Charles Cliff
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after98,701
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.